GUERLAIN LIP PENCIL, BEIGE ROSE 41 (2007 formulation) || Skin Deep: Cosmetic Safety Reviews

GUERLAIN LIP PENCIL, BEIGE ROSE 41 (2007 FORMULATION)

last updated: 12/01/07 brand: Guerlain by Guerlain SA

SCORE

low hazard (out of 10)

81%

data gap

BUY ONLINE/BETTER PRODUCTS

see online retailers

7% of lip liners have lower concerns

COMPANY POLICIES

Compact for Safe Cosmetics
Non-signer: This company has not signed the Compact.

Animal Testing Policy
This company's animal testing policy is unknown.

Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.

Ingredients in this product are linked to:
	Cancer
	Developmental/reproductive toxicity
	Violations, restrictions & warnings
	Allergies/immunotoxicity
	Other concerns for ingredients used in this product: Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Multiple, additive exposure sources, Contamination concerns, Occupational hazards, Biochemical or cellular level changes

Note: This product formulation was obtained from the FDA VCRD.

Ingredients from packaging: CYCLOPENTASILOXANE, TOCOPHEROL, DL-ALPHA, ASCORBYL PALMITATE, MICA, TITANIUM DIOXIDE, IRON OXIDES, PARAFFIN, POLYBUTENE, C11-12 ISOPARAFFIN, HYDROGENATED COTTONSEED OIL, CERESIN, OZOKERITE, MICROCRYSTALLINE WAX, SIMMONDSIA CHINENSIS (JOJOBA) SEED EXTRACT

user reviews & comments

NEW! No reviews or ratings yet. Log in and be the first to leave a comment!

ingredients

	score	data gap	concerns
HYDROGENATED COTTONSEED OIL	8	75%	Contamination concerns (MERCURY, ARSENIC, LEAD, GOSSYPOL, PESTICIDES, PCBS)
TITANIUM DIOXIDE (NON-NANO)	1	81%	Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Occupational hazards, Biochemical or cellular level changes
CYCLOPENTASILOXANE	2	79%	Persistence and bioaccumulation
MICA	3	75%	Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Occupational hazards
IRON OXIDES	2	85%	Persistence and bioaccumulation, Enhanced skin absorption
PARAFFIN	2	80%	Organ system toxicity (non-reproductive), Occupational hazards
CERESIN	0	93%	none identified
MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA)	1	93%	Organ system toxicity (non-reproductive)
POLYBUTENE	1	92%	Organ system toxicity (non-reproductive)
OZOKERITE	1	91%	none identified
TOCOPHEROL, DL-ALPHA	1	90%	none identified
ASCORBYL PALMITATE (VITAMIN C PALMITATE)	1	88%	none identified
C11-12 ISOPARAFFIN	0	100%	none identified
SIMMONDSIA CHINENSIS (JOJOBA) SEED EXTRACT	0	100%	none identified

Cancer*

*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show tumor formation at moderate doses		CYCLOPENTASILOXANE
One or more animal studies show tumor formation at moderate doses		PARAFFIN
One or more in vitro tests on mammalian cells show positive mutation results		TOCOPHEROL, DL-ALPHA, TITANIUM DIOXIDE (NON-NANO)

Violations, restrictions & warnings*

*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications		HYDROGENATED COTTONSEED OIL

Neurotoxicity*

*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show any effects at moderate doses		CYCLOPENTASILOXANE

Endocrine disruption*

*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show endocrine disruption at moderate doses		CYCLOPENTASILOXANE

Allergies/immunotoxicity*

*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show immune effects at low doses		TITANIUM DIOXIDE (NON-NANO)
One or more animal studies show gastrointestinal effects at moderate doses		MICA

Persistence and bioaccumulation*

*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Not suspected to be bioaccumulative		ASCORBYL PALMITATE (VITAMIN C PALMITATE)
Not suspected to be persistent		TOCOPHEROL, DL-ALPHA, POLYBUTENE, HYDROGENATED COTTONSEED OIL, TITANIUM DIOXIDE (NON-NANO), IRON OXIDES, PARAFFIN, MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA)
Persistent, bioaccumulative in wildlife and humans		MICA
Persistent, bioaccumulative in wildlife		CYCLOPENTASILOXANE

Organ system toxicity (non-reproductive)*

*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient)		CYCLOPENTASILOXANE, ASCORBYL PALMITATE (VITAMIN C PALMITATE)
One or more animal studies show sense organ effects at moderate doses (low dose studies may be unavailable for this ingredient)	products for use around the eyes, mouth, or lips	PARAFFIN, OZOKERITE
One or more animal studies show cardiovascular effects at very low doses		TITANIUM DIOXIDE (NON-NANO)
Possible human respiratory toxicant		MICA

Multiple, additive exposure sources*

*This table includes all possible multiple, additive exposure sources concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Low human health concern based on exposure and toxicity		MICA
Moderate human health concern based on exposure and toxicity		POLYBUTENE, TITANIUM DIOXIDE (NON-NANO), PARAFFIN, MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA), CERESIN
Designated as safe for general or specific, limited use in food		TITANIUM DIOXIDE (NON-NANO), IRON OXIDES, ASCORBYL PALMITATE (VITAMIN C PALMITATE), PARAFFIN

Ecotoxicology*

*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Not known to be a wildlife or environmental toxin		POLYBUTENE, HYDROGENATED COTTONSEED OIL, TITANIUM DIOXIDE (NON-NANO), IRON OXIDES, PARAFFIN, MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA), MICA
Wildlife and environmental toxicity		CYCLOPENTASILOXANE, ASCORBYL PALMITATE (VITAMIN C PALMITATE)

Irritation (skin, eyes, or lungs)*

*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show skin irritation at moderate doses		TITANIUM DIOXIDE (NON-NANO), PARAFFIN, OZOKERITE, CYCLOPENTASILOXANE

Data gaps*

*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Pesticide inert of potential toxicological concern		POLYBUTENE
Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product		POLYBUTENE, PARAFFIN, CERESIN, MICROCRYSTALLINE WAX (CERA MICROCRISTALLINA), OZOKERITE, ASCORBYL PALMITATE (VITAMIN C PALMITATE)
Not assessed for safety in cosmetics by industry panel		TOCOPHEROL, DL-ALPHA, TITANIUM DIOXIDE (NON-NANO), SIMMONDSIA CHINENSIS (JOJOBA) SEED EXTRACT, CYCLOPENTASILOXANE, C11-12 ISOPARAFFIN

Occupational hazards*

*This table includes all possible occupational hazards concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Allowed workplace exposures restricted to moderate doses		TITANIUM DIOXIDE (NON-NANO)

Biochemical or cellular level changes*

*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show biochemical changes at low doses where the human health implications are not yet well understood		TITANIUM DIOXIDE (NON-NANO)